Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma

PURPOSE: Although postoperative radioiodine (RAI) therapy has been used in patients with differentiated thyroid carcinoma (DTC) for many years, there is still lack of data defining the timing of RAI administration. A retrospective analysis was carried out to answer the question whether the time of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Krajewska, Jolanta, Jarzab, Michal, Kukulska, Aleksandra, Czarniecka, Agnieszka, Roskosz, Jozef, Puch, Zbigniew, Wygoda, Zbigniew, Paliczka-Cieslik, Ewa, Kropinska, Aleksandra, Krol, Aleksandra, Handkiewicz-Junak, Daria, Jarzab, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821904/
https://www.ncbi.nlm.nih.gov/pubmed/31723361
http://dx.doi.org/10.1007/s13139-019-00608-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821904/
https://www.ncbi.nlm.nih.gov/pubmed/31723361
http://dx.doi.org/10.1007/s13139-019-00608-8

Ejemplares similares